Cidal activity of oral third-generation cephalosporins against Streptococcus pneumoniae in relation to cefotaxime intrinsic activity-Reference-Cited by-同舟云学术

Cidal activity of oral third-generation cephalosporins against Streptococcus pneumoniae in relation to cefotaxime intrinsic activity

Published:2008-02-26 Issue:8 Volume:27 Page:679-683
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Cafini F.,Aguilar L.,Alou L.,Giménez M. J.,Sevillano D.,Torrico M.,González N.,Granizo J. J.,Martín-Herrero J. E.,Prieto J.

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10096-008-0493-7.pdf

Reference15 articles.

1. Pérez-Trallero E, García-de-la-Fuente C, García-Rey C, Baquero F, Aguilar L, Dal-Ré R, García-de-Lomas J; Spanish Surveillance Group for Respiratory Pathogens (2005) Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain. Antimicrob Agents Chemother 49:1965–1972

2. Pérez-Trallero E, Marimón JM, Ercibengoa M, Coronel P, Giménez MJ, Aguilar L (2007) Antimicrobial susceptibilities of amoxycillin-non-susceptible and susceptible isolates among penicillin-non-susceptible Streptococcus pneumoniae. Clin Microbiol Infect 13:937–940

3. Fenoll A, Giménez MJ, Robledo O, Aguilar L, Tarragó D, Granizo JJ, Martín-Herrero JE (2008) Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 27:75–80

4. Amsterdam D (1996) Susceptibility testing on antimicrobials in liquid media. In: Lorian V (ed) Antibiotics in laboratory medicine, 4th edn. Lippincott Williams & Wilkins, Baltimore, pp 52–111

5. Craig WA (1995) Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn Microbiol Infect Dis 22:89–96

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comment on the article: In vivo Pharmacokinetics/Pharmacodynamics Profiles for Appropriate Doses of Cefditoren pivoxil against S. pneumoniae in Murine Lung-Infection Model;Pharmaceutical Research;2024-07-13

2. Current microbiological aspects of community respiratory infection beyond COVID-19;Revista Española de Quimioterapia;2021-03-22

3. The study of antiviral drugs targeting SARS-CoV-2 nucleocapsid and spike proteins through large-scale compound repurposing;Heliyon;2021-03

4. Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults;Multidisciplinary Respiratory Medicine;2018-11-02

5. Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in Central Thailand, 2009–2012;Human Vaccines & Immunotherapeutics;2014-04-23